These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27481653)

  • 1. Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells.
    Langouet-Astrie CJ; Yang Z; Polisetti SM; Welsbie DS; Hauswirth WW; Zack DJ; Merbs SL; Enke RA
    Exp Eye Res; 2016 Oct; 151():61-7. PubMed ID: 27481653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of immediate inflammatory responses after intravitreal AAV2 injection in rats by optical coherence tomography.
    Liu YF; Huang S; Ng TK; Liang JJ; Xu Y; Chen SL; Xu C; Zhang M; Pang CP; Cen LP
    Exp Eye Res; 2020 Apr; 193():107955. PubMed ID: 32017940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors governing the transduction efficiency of adeno-associated virus in the retinal ganglion cells following intravitreal injection.
    Cao X; Yung J; Mak H; Leung CKS
    Gene Ther; 2019 Apr; 26(3-4):109-120. PubMed ID: 30692605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
    Reid CA; Ertel KJ; Lipinski DM
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of SNCG and NEFH Promoter-Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma.
    O'Neill N; Meng M; Chaqour B; Dine K; Sarabu N; Pham JC; Shindler KS; Ross AG
    Transl Vis Sci Technol; 2024 Aug; 13(8):37. PubMed ID: 39177995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV2-Mediated Transduction of the Mouse Retina After Optic Nerve Injury.
    Nickells RW; Schmitt HM; Maes ME; Schlamp CL
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6091-6104. PubMed ID: 29204649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of adeno-associated viral vector labelled retinal ganglion cells.
    Smith CA; Chauhan BC
    Sci Rep; 2018 Jan; 8(1):1490. PubMed ID: 29367685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates.
    Tshilenge KT; Ameline B; Weber M; Mendes-Madeira A; Nedellec S; Biget M; Provost N; Libeau L; Blouin V; Deschamps JY; Le Meur G; Colle MA; Moullier P; Pichard V; Rolling F
    Hum Gene Ther Methods; 2016 Jun; 27(3):122-34. PubMed ID: 27229628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells.
    Leaver SG; Cui Q; Plant GW; Arulpragasam A; Hisheh S; Verhaagen J; Harvey AR
    Gene Ther; 2006 Sep; 13(18):1328-41. PubMed ID: 16708079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma.
    Wójcik-Gryciuk A; Gajewska-Woźniak O; Kordecka K; Boguszewski PM; Waleszczyk W; Skup M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal ganglion cell death and optic nerve degeneration by genetic ablation in adult mice.
    Cho JH; Mu X; Wang SW; Klein WH
    Exp Eye Res; 2009 Mar; 88(3):542-52. PubMed ID: 19109949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis.
    McDougald DS; Dine KE; Zezulin AU; Bennett J; Shindler KS
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1212-1220. PubMed ID: 29494741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin activation causes retinal ganglion cell degeneration.
    Qu J; Matsouaka R; Betensky RA; Hyman BT; Grosskreutz CL
    Mol Vis; 2012; 18():2828-38. PubMed ID: 23233785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.
    Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR
    Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.
    Mowat FM; Gornik KR; Dinculescu A; Boye SL; Hauswirth WW; Petersen-Jones SM; Bartoe JT
    Gene Ther; 2014 Jan; 21(1):96-105. PubMed ID: 24225638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.
    Boye SE; Alexander JJ; Witherspoon CD; Boye SL; Peterson JJ; Clark ME; Sandefer KJ; Girkin CA; Hauswirth WW; Gamlin PD
    Hum Gene Ther; 2016 Aug; 27(8):580-97. PubMed ID: 27439313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury.
    Chiha W; Bartlett CA; Petratos S; Fitzgerald M; Harvey AR
    Exp Neurol; 2020 Apr; 326():113167. PubMed ID: 31904385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.
    Martin KR; Quigley HA; Zack DJ; Levkovitch-Verbin H; Kielczewski J; Valenta D; Baumrind L; Pease ME; Klein RL; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4357-65. PubMed ID: 14507880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative impact of rAAV2 mediated expression of SOCS3 on the regeneration of adult retinal ganglion cell axons.
    Hellström M; Muhling J; Ehlert EM; Verhaagen J; Pollett MA; Hu Y; Harvey AR
    Mol Cell Neurosci; 2011 Feb; 46(2):507-15. PubMed ID: 21145973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of
    Shiozawa AL; Igarashi T; Kobayashi M; Nakamoto K; Kameya S; Fujishita S; Takahashi H; Okada T
    Mol Vis; 2020; 26():409-422. PubMed ID: 32565669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.